During the past decade, Az.Ospedaliera S.G.Moscati conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Az.Ospedaliera S.G.Moscati" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 22 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Associazione Qol-one" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Az.Ospedaliera S.G.Moscati" #1 collaborator was "Acute Leukemia French Association" with 1 trials as a collaborator, "BUPA Foundation" with 1 trials as a collaborator, "Clinical research technology Srl" with 1 trials as a collaborator, "Fondazione IRCCS Policlinico San Matteo di Pavia" with 1 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Az.Ospedaliera S.G.Moscati" are "Leukemia" (8 trials), "Myelodysplastic Syndromes" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Myeloid Leukemia" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (3 trials). Many other conditions were trialed in "Az.Ospedaliera S.G.Moscati" in a lesser frequency.

Most popular intervention types in "Az.Ospedaliera S.G.Moscati" are "Drug" (43 trials), "Other" (12 trials), "Procedure" (8 trials), "Radiation" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "mercaptopurine" (5 trials), "methotrexate" (5 trials), "Placebo" (4 trials), "cyclophosphamide" (4 trials) and "cytarabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Az.Ospedaliera S.G.Moscati" are 59 trials for "All" genders.

Currently, there are NaN active trials in "Az.Ospedaliera S.G.Moscati". undefined are not yet recruiting, 7 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Az.Ospedaliera S.G.Moscati, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Az.Ospedaliera S.G.Moscati, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".

Az.Ospedaliera S.G.Moscati has several departments that took part in Clinical trials: "Azienda Ospedaliera S. Giuseppe Moscati, U.O. di Oncologia Medica" - 9 trials, "Division of Cardiology Ao Moscati" - 2 trials